# Step-by-step guide and checklists for selecting and conducting an evidence synthesis study using a framework for approaches and methods in evidence synthesis (FRAMES)

**Authors:** Alok Kumar Dwivedi

PMC · DOI: 10.7717/peerj.20897 · PeerJ · 2026-03-06

## TL;DR

This paper provides a comprehensive framework and checklists to guide researchers in conducting high-quality systematic reviews and meta-analyses.

## Contribution

The novel contribution is a consolidated framework (FRAMES) with step-by-step guidance and checklists for evidence synthesis methods.

## Key findings

- The framework clarifies the selection and execution of systematic reviews and meta-analyses.
- It highlights challenges in current systematic reviews and offers solutions.
- Checklists and writing steps are provided to improve the quality of evidence synthesis.

## Abstract

Findings from multiple studies are used to develop informed decisions for future research and clinical practices. Evidence synthesis methods, in general, are recommended for synthesizing findings from multiple studies. Among all evidence synthesis methods, a high-quality systematic review is required for answering a specific, focused research question from an abundance of literature. Although the choice of a systematic review among all other evidence syntheses depends on the formulated question related to estimation or hypothesis, and the availability of high-quality original studies, evidence syntheses not adhering to systematic review guidelines are also referred to as systematic reviews in the literature. Moreover, planning, designing, analyzing, and reporting a systematic review and meta-analysis requires multiple steps that are not included in the standard checklist documents, such as preferred reporting items for systematic review and meta-analysis (PRISMA) or meta-analysis of observational studies in epidemiology (MOOSE). It is also unclear to investigators how to properly select a type of evidence synthesis method and the steps involved in conducting a meta-analysis. Although multiple documents are available for selecting appropriate evidence synthesis methods, writing a protocol for a systematic review and meta-analysis, and conducting meta-analyses, there is no single report that consolidates all of these in a comprehensive framework. Given emerging challenges in the quality of published systematic reviews, this report aims to facilitate a framework for approaches and methods in evidence synthesis (FRAMES) to readers in (a) understanding types of evidence synthesis methods with specific focus to a systematic reviews and meta-analyses, (b) explaining the objectives of meta-analysis study, (c) describing the steps and resources in conducting a systematic review and meta-analysis, and (d) exemplifying the challenges and their potential solutions in a meta-analysis study. This report provides evidence-based biostatistics checklists for conducting a systematic review and meta-analysis, and writing steps for a systematic review study. I believe the adoption of this guidance document in research and training for the conduct and writing of an evidence synthesis study can have a far-reaching impact on producing high-quality evidence for research and clinical practices.

## Full-text entities

- **Genes:** APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}
- **Diseases:** coronavirus disease (MESH:D018352), PCOS (MESH:D011085), COVID-19 (MESH:D000086382), neuropsychiatric (MESH:C000631768), CVD (MESH:D002318), depressive disorder (MESH:D003866), GLM (MESH:D005910), autism spectrum disorder (MESH:D000067877), AD (MESH:D000544), lung cancer (MESH:D008175), multiple myeloma (MESH:D009101), LOOA (MESH:D000070591), anxiety disorder (MESH:D001008)
- **Chemicals:** melphalan (MESH:D008558), AD (-), prednisone (MESH:D011241), testosterone (MESH:D013739), progesterone (MESH:D011374), thalidomide (MESH:D013792)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** CEM — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0207)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12970308/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12970308/full.md

## References

85 references — full list in the complete paper: https://tomesphere.com/paper/PMC12970308/full.md

---
Source: https://tomesphere.com/paper/PMC12970308